No Photo Available

Last Update

2017-02-20T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Elaine Mardis?

Dr. Elaine R. Mardis

Direct Phone: (314) ***-****       

Email: e***@***.edu

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Washington University

One Brookings Drive

St. Louis, Missouri 63130

United States

Company Description

Washington University in St. Louis is a medium-sized, independent research university dedicated to challenging its faculty and students alike to seek new knowledge and greater understanding of an ever-changing, multicultural world. The university is count ... more

Find other employees at this company (137,010)

Background Information

Employment History

Senior Research Scientist

Bio-Rad Laboratories Inc

Chair of the Basic and Translational Sciences

American College of Surgeons

Affiliations

Scientific Advisory Board Member
CGEn

Scientific Advisory Boards
dnanexus inc.

Scientific Advisory Boards
QIAGEN N.V.

Center Member
Children's Discovery Institute

Board Member
American Association for Cancer Research Inc

Editorial Board Member
Molecular Cancer Research , Genome Research and Molecular Oncology

Scientific Advisor
Orion Genomics LLC

Scientific Advisory Boards
Pacific Biosciences Inc

Scientific Advisory Board Member
Ingenuity Systems Inc

Scientific Advisory Boards
Edge Biosystems Inc

Board Member
Applied Biosystems Inc.

Member
American Society of Human Genetics

Board Member
Applera Corporation

Member
Discovery Institute

Editorial Board Member of Molecular Cancer Research
Disease Models

Organizing Committee
AGBT-Precision Health

Education

B.S.

Zoology

Oklahoma University

B.S. degree

zoology

University of Oklahoma

Ph.D.

National Human Genome Research Institute

Ph.D.

The Genome Institute of Washington University

Ph.D.

Washington University

Ph.D.

Washington University School of Medicine

Ph.D.

Biochemistry and Chemistry

University of Oklahoma

Ph.D.

Chemistry and Biochemistry

Oklahoma University

PhD

Scripps Translational Science Institute

PhD

The Genome Institute at Washington University

Web References (196 Total References)


ZS Genetics Management Team

www.zsgenetics.com [cached]

Elaine R. Mardis, PhD (SAB Chair) Dr. Elaine Mardis graduated Phi Beta Kappa from the University of Oklahoma with a B.S. degree in zoology. She then completed her Ph.D. in Chemistry and Biochemistry in 1989, also at Oklahoma. Following graduation, Dr. Mardis was a senior research scientist for four years at BioRad Laboratories in Hercules, CA.

In 1993, Dr. Mardis joined The Genome Institute at Washington University School of Medicine. As Director of Technology Development, she helped create methods and automation pipelines for sequencing the Human Genome. She currently orchestrates the Center's efforts to explore massively parallel sequencing technologies and to transition them into production sequencing capabilities as well as new applications.
Dr. Mardis has research interests in the application of DNA sequencing to characterize cancer genomes and transcriptomes, and using these data to support therapeutic decision-making. She also is interested in facilitating the translation of basic science discoveries about human disease into the clinical setting.
Dr. Mardis serves as an editorial board member of Molecular Cancer Research, Genome Research and Molecular Oncology, and acts as a reviewer for Nature, the New England Journal of Medicine, Cell and Genome Research. She serves on the scientific advisory boards of Qiagen Ingenuity, DNA Nexus, and ZS Genetics. Dr. Mardis received the Scripps Translational Research award for her work on cancer genomics in 2010, and was named a Distinguished Alumni of the University of Oklahoma College of Arts and Sciences for 2011. She is the former chair of Basic and Translational Sciences for the American College of Surgeons Oncology Group (ACOSOG).
Further information is available on Dr. Mardis at genome.wustl.edu/people/individual/elaine-mardis/.


Elaine Mardis, Ph.D., ...

www.oriongenomics.com [cached]

Elaine Mardis, Ph.D., Assistant Professor of Genetics Washington University School of Medicine

In addition to serving as Assistant Professor of Genetics, Washington University School of Medicine, Dr. Mardis is also the co-director of the Washington University Genome Sequencing Center where she leads the Technology Development group. Dr. Mardis is an expert in the development of DNA sequencing technology and is responsible for the many procedures and high-throughput automated systems currently in use at the Genome Sequencing Center. Dr. Mardis has served as a technical consultant for several commercial high-throughput sequencing laboratories, including Monsanto and Millennium Pharmaceuticals. Dr. Mardis received her Ph.D. in Chemistry from the University of Oklahoma.


Automated DNA Sequencing Industry: Far From Commoditization ยป Sides & Associates

sidesandassociates.com [cached]

According to Elaine Mardis, a geneticist at Washington University, as quoted recently in Forbes, the new HiSeq 2000 Illumina machine is perfect for researchers like herself who need to sequence a lot of DNA.


Non-Profit Startup Paradigm Launches Cancer Panel Based on DNA, RNA Sequencing | Paradigm

www.paradigmdx.com [cached]

Others have also noted the importance of sequencing RNA to confirm DNA sequencing results, including Elaine Mardis, co-director of the Genome Institute at Washington University, who in 2011 said that about only 40 percent of mutations in a patient's genome is actually expressed, and added that in looking for target mutations for a drug, targeting mutations in genes that aren't even expressed is probably a fruitless exercise.


2016 Precision Health Meeting Speakers | AGBT

www.agbt.org [cached]

Elaine Mardis, Ph.D., graduated Phi Beta Kappa from the University of Oklahoma with a B.S. degree in zoology. She then completed her Ph.D. in Chemistry and Biochemistry in 1989, also at Oklahoma. Following graduation, Dr. Mardis was a senior research scientist for four years at BioRad Laboratories in Hercules, CA.

In 1993, Dr. Mardis joined the faculty at Washington University School of Medicine. Recruited for her expertise in DNA sequencing and automation technology, she served as Director of Technology Development at the (then) Washington University Genome Sequencing Center, helping create methods and automation pipelines for sequencing the Human Genome. She has served as Co-director of the McDonnell Genome Institute since 2002. In 2014, Dr. Mardis was named the Robert E. and Louise F. Dunn Distinguished Professor of Medicine.
...
Dr. Mardis has research interests in the application of next-generation sequencing to characterize cancer genomes and transcriptomes, and using these data to support therapeutic decision-making. She co-led the teams that first used next-generation sequencing to characterize the whole genome of an AML patient (Nature 2008), first sequenced and compared a primary tumor to its metastasis and xenograft, and first reported whole genome sequencing of samples from a breast cancer clinical trial. Beyond cancer genomics discoveries, Dr. Mardis is leading efforts to facilitate the translation of basic science discoveries about human genetic diseases into the clinical setting, especially focused on the use of next-generation sequencing. Her translational research efforts aim to devise NGS-based diagnostics, decision-support tools and databases, and the use of genomics to design personalized cancer vaccines.
Dr. Mardis was elected to the AACR Board of Directors in 2015. She serves as an associate editor of Molecular Cancer Research, Disease Models and Mechanisms and Annals of Oncology, and acts as a reviewer for Nature, the New England Journal, Cell and Science. She is the Editor-in-Chief of Molecular Case Studies. She serves on the scientific advisory boards of Qiagen Ingenuity, DNA Nexus, and ZS Genetics, and is a member of the Supervisory Board of Qiagen N.V. Dr. Mardis received the 2010 Scripps Translational Research award for her work on cancer genomics, and was named a Distinguished Alumni of the University of Oklahoma College of Arts and Sciences in 2011. Discover Magazine featured her work in cancer genomics as one of their top 100 science stories of 2013. In 2014 and 2015, she was one of the most highly cited researchers in the world, according to Thompson-Reuters. She will receive the Morton K. Schwartz award from the American Association of Clinical Chemistry for Significant Contributions in Cancer Research Diagnostics in 2016.

Similar Profiles

Other People with this Name

Other people with the name Mardis

Tom Mardis
Vero Beach Press Journal

Whitney Mardis
US WorldMeds LLC

Laurie Mardis
BTC Capital Management

Jeff Mardis
Rainbow Design Services , Inc.

Terrance Mardis
University of North Carolina

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory